BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Oct 27, 2008
 |  BC Week In Review  |  Clinical News  |  Regulatory

Prezista darunavir regulatory update

FDA approved a label expansion for once-daily Prezista darunavir tablets to treat HIV infection in combination with antiretroviral agents in antiretroviral treatment-experienced patients. The agency...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >